ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 219 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,573,000 | -12.7% | 60,000 | 0.0% | 0.25% | -9.7% |
| Q2 2021 | $4,092,000 | -1.7% | 60,000 | 0.0% | 0.28% | -4.1% |
| Q1 2021 | $4,163,000 | -22.6% | 60,000 | -14.3% | 0.29% | -33.9% |
| Q4 2020 | $5,378,000 | -65.9% | 70,000 | -66.8% | 0.44% | -68.7% |
| Q3 2020 | $15,764,000 | +18.8% | 210,778 | 0.0% | 1.40% | -2.2% |
| Q2 2020 | $13,268,000 | +31.6% | 210,778 | -12.2% | 1.43% | +1.5% |
| Q1 2020 | $10,080,000 | +0.9% | 240,000 | +9.1% | 1.41% | +28.9% |
| Q4 2019 | $9,992,000 | +40.9% | 220,000 | +41.9% | 1.10% | +23.2% |
| Q3 2019 | $7,094,000 | -28.8% | 155,000 | -8.8% | 0.89% | -19.0% |
| Q2 2019 | $9,967,000 | -5.2% | 170,000 | -27.5% | 1.10% | -10.7% |
| Q1 2019 | $10,515,000 | -27.4% | 234,558 | -36.9% | 1.23% | -25.7% |
| Q4 2018 | $14,484,000 | -14.1% | 371,858 | +1.5% | 1.66% | -2.0% |
| Q3 2018 | $16,861,000 | +35.9% | 366,387 | +28.7% | 1.69% | +33.1% |
| Q2 2018 | $12,409,000 | +10.0% | 284,621 | -0.4% | 1.27% | -8.7% |
| Q1 2018 | $11,283,000 | -13.9% | 285,642 | -25.9% | 1.39% | -21.4% |
| Q4 2017 | $13,100,000 | -9.8% | 385,642 | -32.3% | 1.77% | -4.5% |
| Q3 2017 | $14,522,000 | – | 569,491 | – | 1.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |